TITLE

Therapeutic Antibodies in HIV Treatment - Classical Approaches to Novel Advances

AUTHOR(S)
Abela, Irene A.; Reynell, Lucy; Trkola, Alexandra
PUB. DATE
November 2010
SOURCE
Current Pharmaceutical Design;11/28/2010, Vol. 16 Issue 33, p3754
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
61924765

 

Related Articles

  • AIDS HOPE. Groopman, Jerome // New Republic;4/3/95, Vol. 212 Issue 14, p18 

    Calls for additional U.S. federal research funding and spending for HIV and AIDS treatment. Significance of the advances in molecular technology to AIDS treatment research; Manner in which HIV destroys the immune system; Progress in AIDS treatment research as of 1995.

  • Reviews and comment from the nature publishing group.  // Nature Reviews Immunology;Mar2005, Vol. 5 Issue 3, p261 

    Comments on several research on immunology. "Induction and Suppression of RNA Silencing: Insights From Viral Infections," by O. Voinnet; "A Toll-like Trigger for Autoimmune Disease," by J. F. Bach; "Integrase Inhibitors to Treat HIV/AIDS," by Y. Pommler, A. Johnson and C. Marchand.

  • HIV aşısı. Yarpuzlu, Aysegul Akbay // Turkish Journal of Biochemistry / Turk Biyokimya Dergisi;Sep2011, Vol. 36 Issue 3, p273 

    An HIV vaccine is a hypothetical vaccine against HIV, the etiological agent of AIDS. As there is no known cure for AIDS, the search for a vaccine has become part of the struggle against the disease. An HIV vaccine is generally considered as the most likely, and perhaps the only way by which the...

  • HIV treatment and eradication in South Africa. Kotwal, Girish J. // Journal of the Royal Society of Medicine;Jan2004, Vol. 97 Issue 1, p1 

    The author reflects on HIV treatment and the preventive efforts of South Africa. The author inferred that the new hope emerging against a looming AIDS pandemic in the region can be attributed to the drastic reduction of antiretroviral drug prices by pharmaceutical firms and the treatment...

  • HIV/AIDS -- Accomplishments and challenges? DAMLE, S. G. // Contemporary Clinical Dentistry;Oct-Dec2013, Vol. 4 Issue 4, p419 

    The article focuses on the accomplishments and challenges for HIV/AIDS research in 2013. Topics discussed include the efficacy of antiretroviral treatment in preventing mother-to-child transmission, the use of radioactive monoclonal antibodies to destroy leukemia cells, and the effect of...

  • Functional Characterization of Two scFv-Fc Antibodies from an HIV Controller Selected on Soluble HIV-1 Env Complexes: A Neutralizing V3- and a Trimer-Specific gp41 Antibody. Trott, Maria; Weiβ, Svenja; Antoni, Sascha; Koch, Joachim; von Briesen, Hagen; Hust, Michael; Dietrich, Ursula // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    HIV neutralizing antibodies (nAbs) represent an important tool in view of prophylactic and therapeutic applications for HIV-1 infection. Patients chronically infected by HIV-1 represent a valuable source for nAbs. HIV controllers, including long-term non-progressors (LTNP) and elite controllers...

  • Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Reynolds, John; Khan, Sarah B.; Allen, Andrew R.; Benjamin, Christopher D.; Pusey, Charles D. // Kidney International;Oct2004, Vol. 66 Issue 4, p1444 

    Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis.Background.Experimental autoimmune glomerulonephritis (EAG) was induced in Wistar-Kyoto (WKY) rats by immunization with rat glomerular basement membrane (GBM) in adjuvant. This...

  • What's New in ...  // JAAPA: Journal of the American Academy of Physician Assistants (;Dec2009, Vol. 22 Issue 12, p54 

    The article explains what physician assistants (PAs) should know about the immune reconstitution inflammatory syndrome (IRIS) or immune restoration disease. It describes the pathogenesis of the disease. It presents a case study of a 30-year-old woman with HIV/AIDS and pulmonary M avium infection...

  • Development of resistance in HIV-1 infection: case report.  // Reactions Weekly;11/24/2012, Issue 1429, p17 

    An abstract of the article "The efficacy of an anti-DC4 monoclonal antibody for HIV-1 treatment," by W. J. Fessel and colleagues is presented.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics